Last $0.0001 USD
Change Today 0.00 / 0.00%
Volume 0.0
INGNQ On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Elizabeth Grimm Ph.D.

Member of the Scientific Advisory Board, Introgen Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 1 different industries.

See Board Relationships
----

Background*

Elizabeth Grimm, Ph.D., is a Professor of Cancer Biology at University of Texas M.D. Anderson Cancer Center. Dr. Grimm serves as the Member of Scientific Advisory Board at Pivotal BioSciences, Inc. and Introgen Therapeutics Inc. She is a noted investigator of T-cell immunity who has devoted a large part of her career to the study and use of IL-2 for the treatment of cancer.

Corporate Headquarters*

8066 El Rio
Houston, Texas 77054

United States

Phone: 713-842-1017
Fax: 713-842-6660

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
University of California, Los Angeles, School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INGNQ:US $0.00 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTROGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.